Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Theravance says FDA asked for data on risks and revised label for 'superbug' treatment
Theravance says FDA asked for data on risks and revised label for 'superbug' treatment
Theravance says FDA asked for data on risks and revised label for 'superbug' treatment
Submitted by
admin
on February 27, 2009 - 10:12am
Source:
Yahoo/AP
News Tags:
Theravance
FDA
televancin
Headline:
Theravance says FDA asked for data on risks and revised label for 'superbug' treatment
Do Not Allow Advertisers to Use My Personal information
